Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 3
2018 2
2019 1
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition.
Li Y, Dobrolecki LE, Sallas C, Zhang X, Kerr TD, Bisht D, Wang Y, Awasthi S, Kaundal B, Wu S, Peng W, Mendillo ML, Lu Y, Jeter CR, Peng G, Liu J, Westin SN, Sood AK, Lewis MT, Das J, Yi SS, Bedford MT, McGrail DJ, Sahni N. Li Y, et al. Cell Rep Med. 2023 Dec 19;4(12):101326. doi: 10.1016/j.xcrm.2023.101326. Cell Rep Med. 2023. PMID: 38118413 Free PMC article.
Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia.
Hegde NC, Kumar A, Kaundal S, Saha L, Malhotra P, Prinja S, Lad D, Patil AN. Hegde NC, et al. Ann Hematol. 2023 Nov;102(11):3125-3132. doi: 10.1007/s00277-023-05342-y. Epub 2023 Jul 13. Ann Hematol. 2023. PMID: 37439892
In conclusion, generic ibrutinib is a cost-effective initial line of management compared to other commonly used treatment regimes in resource-limited settings....
In conclusion, generic ibrutinib is a cost-effective initial line of management compared to other commonly used treatment regimes in …
Environmental surveillance of polioviruses with special reference to L20B cell line.
Kaundal N, Sarkate P, Prakash C, Rishi N. Kaundal N, et al. Virusdisease. 2017 Dec;28(4):383-389. doi: 10.1007/s13337-017-0409-1. Epub 2017 Nov 28. Virusdisease. 2017. PMID: 29291229 Free PMC article.
L20B and RD cell lines are used for isolation of polioviruses. It is imperative to study the efficacy of these cell line in isolating polioviruses from environmental samples. The present study was carried out to determine the sensitivity and specificity of L20B cell lin …
L20B and RD cell lines are used for isolation of polioviruses. It is imperative to study the efficacy of these cell line in isolating …
Nanomelatonin triggers superior anticancer functionality in a human malignant glioblastoma cell line.
Kumar Yadav S, Kumar Srivastava A, Dev A, Kaundal B, Roy Choudhury S, Karmakar S. Kumar Yadav S, et al. Nanotechnology. 2017 Aug 18;28(36):365102. doi: 10.1088/1361-6528/aa7c76. Online ahead of print. Nanotechnology. 2017. PMID: 28820142
Our study has shown for the first time that MEL-CS nanocomposites are therapeutically more effective as compared to free MEL at inducing functional anticancer efficacy in the human brain tumour U87MG cell line....
Our study has shown for the first time that MEL-CS nanocomposites are therapeutically more effective as compared to free MEL at inducing fun …
Targeting endothelin receptors for pharmacotherapy of ischemic stroke: current scenario and future perspectives.
Kaundal RK, Deshpande TA, Gulati A, Sharma SS. Kaundal RK, et al. Drug Discov Today. 2012 Jul;17(13-14):793-804. doi: 10.1016/j.drudis.2012.02.017. Epub 2012 Mar 8. Drug Discov Today. 2012. PMID: 22406696
Many attempts have been made to target ET receptors in various animal models of stroke, but it is very difficult to draw a definite line of conclusion, because these studies differ in many aspects, such as animal model, treatment schedule, parameters and techniques used fo …
Many attempts have been made to target ET receptors in various animal models of stroke, but it is very difficult to draw a definite line …